Approval · Notice of Compliance 29196 · 2022
NINLARO: Notice of Compliance 29196
Issued October 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29196
- Date
- October 13, 2022
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph with new safety and clinical information.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NINLARO | Not yet assigned | — |
Medicinal ingredients
- IXAZOMIB CITRATE 4 MG per CAP
- IXAZOMIB CITRATE 3 MG per CAP
- IXAZOMIB CITRATE 2.3 MG per CAP